Optimizing Gait Rehabilitation for Veterans With Non-traumatic Lower Limb Amputation (GEM)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03995238 |
Recruitment Status :
Recruiting
First Posted : June 21, 2019
Last Update Posted : May 12, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Transtibial Amputation Peripheral Artery Disease Diabetes Mellitus | Behavioral: Error-augmentation gait training Behavioral: Error-correction gait training Behavioral: Supervised walking | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 54 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Intervention Model Description: | Randomized controlled trial; Three groups |
Masking: | Double (Investigator, Outcomes Assessor) |
Masking Description: | Outcome assessors will be blinded to group assignment and participants will be reminded at the time of testing to not disclose any aspects of the training sessions. The Principal Investigator will also remain blinded to group assignment. A co-investigator, who is not involved in participant testing/intervention, will manage randomization and maintenance of group assignment codes. |
Primary Purpose: | Treatment |
Official Title: | Optimizing Gait Rehabilitation for Veterans With Non-Traumatic Lower Limb Amputation |
Actual Study Start Date : | October 9, 2019 |
Estimated Primary Completion Date : | October 31, 2023 |
Estimated Study Completion Date : | October 31, 2023 |

Arm | Intervention/treatment |
---|---|
Experimental: Error-augmentation training
A 4-week, 8 session, treadmill-based gait training program, with error-augmentation of step asymmetry delivered on a split-belt treadmill. Each training session will adhere to the same schedule. During the training blocks on the treadmill, the belt under the limb with the shorter step length will be set at 3/4 of the pre-intervention over-ground self-selected walking speed while the belt under the limb with the longer step length will be set to 1/2 of the fast belt speed (2:1 ratio between belts).
|
Behavioral: Error-augmentation gait training
Split-belt treadmill training to enhance between-limb asymmetry during treadmill walking, which is intended to force compensation and correction of step asymmetry during treadmill walking. The error-augmentation gait training program is delivered in 8 sessions over 4 weeks. |
Experimental: Error-correction training
A 4-week, 8 session, treadmill-based gait training program, with error-correction of step asymmetry delivered with an auditory metronome signal while walking on a treadmill. During each training block, the metronome will be set to overcorrect stance time asymmetry through use of asymmetrical metronome tones, 2:1 ratio.
|
Behavioral: Error-correction gait training
Metronome will be set to cue participants to overcorrect between-limb step asymmetry during treadmill walking, through use of asymmetrical metronome tones in a 2:1 ratio. The error-correction gait training program is delivered in 8 sessions over 4 weeks. |
Active Comparator: Supervised waking
A 4-week, 8 session, treadmill-based supervised walking program. The active comparator group will participate in a supervised treadmill walking program of the same frequency and duration, to the two experimental groups.
|
Behavioral: Supervised walking
An active comparator intervention, in which a supervised treadmill walking program is delivered without attempt to correct step asymmetry. The supervised walking program is delivered in 8 sessions over 4 weeks. |
- Step Length Symmetry [ Time Frame: Change from baseline (pre-intervention) to intervention end, persisting at 12 weeks after intervention end. ]Measurement of step length symmetry by overground walking on GAITRite mat and kinetic and kinematic measurements using 3-D motion capture system.
- Six-minute walk test [ Time Frame: Change from baseline (pre-intervention) to intervention end, persisting at 12 weeks after intervention end. ]Physical function test measuring the total distance walked in a span of six minutes.
- Free-living daily step count [ Time Frame: Change from baseline (pre-intervention) to intervention end, persisting at 12 weeks after intervention end. ]Accelerometer-based measurement of free-living daily step count
- World Health Organization Disability Assessment Scale 2.0 [ Time Frame: Change from baseline (pre-intervention) to intervention end, persisting at 12 weeks after intervention end. ]Self-reported assessment of disability using a scale from 0 to 100, with 0 representing no disability, and 100 representing full disability.
- Transcutaneous oximetry [ Time Frame: Change from baseline (pre-intervention) to intervention end, persisting at 12 weeks after intervention end. ]Measurement of residual limb integumentary health.
- Socket Comfort Score [ Time Frame: Change from baseline (pre-intervention) to intervention end, persisting at 12 weeks after intervention end. ]Measurement of limb-socket interface by rating of prosthetic socket fit using a scale from 0 to 10, with 0 representing the most uncomfortable socket fit and 10 representing the most comfortable socket fit.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 50 Years to 89 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Unilateral, non-traumatic, transtibial amputation
- Diabetes mellitus and/or peripheral artery disease
- Able to ambulate in the community without assistive device
- Step length asymmetry during walking (>1.0 asymmetry index.)
- 6 months to 10 years since amputation
Exclusion Criteria:
-
Unstable heart condition
- including unstable angina, uncontrolled cardiac dysrhythmia, acute myocarditis, hypertension, and acute pericarditis
- Acute systemic infection
- Active cancer treatment
- Traumatic or cancer related amputation etiology

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03995238
Contact: Cory L Christiansen, PhD | (303) 724-9101 | Cory.Christiansen@va.gov | |
Contact: Noel L So, MD | (303) 399-8020 | noel.so@va.gov |
United States, Colorado | |
Rocky Mountain Regional VA Medical Center, Aurora, CO | Recruiting |
Aurora, Colorado, United States, 80045 | |
Contact: Noel L So, MD 303-399-8020 noel.so@va.gov | |
Contact: Thomas Fields, DPT (720) 723-3372 thomas.fields@va.gov | |
Principal Investigator: Cory L. Christiansen, PhD |
Principal Investigator: | Cory L. Christiansen, PhD | Rocky Mountain Regional VA Medical Center, Aurora, CO |
Responsible Party: | VA Office of Research and Development |
ClinicalTrials.gov Identifier: | NCT03995238 |
Other Study ID Numbers: |
A3237-R |
First Posted: | June 21, 2019 Key Record Dates |
Last Update Posted: | May 12, 2022 |
Last Verified: | May 2022 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Plan Description: | Participant data will be made available at time of study completion, per VA recommendations and approval. |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Product Manufactured in and Exported from the U.S.: | No |
Amputation Rehabilitation Gait Training Diabetes Peripheral Artery Disease |
Peripheral Arterial Disease Atherosclerosis Arteriosclerosis Arterial Occlusive Diseases |
Vascular Diseases Cardiovascular Diseases Peripheral Vascular Diseases |